Jubilant Ingrevia Accelerates Shift to Specialty, Faces Commodity Risks
Jubilant Ingrevia’s ₹2,000-crore specialty bet starts paying off as CDMO, nutrition drive growth The Breakdown Jubilant Ingrevia, a leading player in the Indian specialty chemicals and ingredients sector, has commenced reaping financial and strategic rewards from a ₹2,000-crore investment push. The company has strategically shifted away from cyclical and low-margin